4888 — Stella Pharma Balance Sheet
0.000.00%
- ¥11bn
- ¥8bn
- ¥269m
Annual balance sheet for Stella Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,007 | 1,251 | 3,276 | 2,710 | 2,354 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 41.4 | 55.1 | 16.9 | 59.3 | 76.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,401 | 1,811 | 4,175 | 3,793 | 3,629 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 68.2 | 68.5 | 92 | 103 | 81.5 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,660 | 2,049 | 4,719 | 4,329 | 3,821 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 308 | 319 | 308 | 422 | 456 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,970 | 1,818 | 1,639 | 1,577 | 1,444 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 690 | 231 | 3,080 | 2,753 | 2,377 |
Total Liabilities & Shareholders' Equity | 2,660 | 2,049 | 4,719 | 4,329 | 3,821 |
Total Common Shares Outstanding |